Silence Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Silence Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Silence Therapeutics Plc - ADR
Rating: 1.10758325
Author: Trendlyne DVM scores

about

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

5.00 0.00 (0.00%)

35.73% Fall from 52W High

95,929

XNAS Volume

XNAS 20 Feb, 2026 4:30 PM (EST)

Board Meeting

The next board meeting for Silence Therapeutics PLC (ADR) is on 27 Feb 2026 for the purpose of Silence Therapeutics PLC Fourth Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

7.3 / 100

Technically Neutral

37.0 / 100

1Yr Price target upside is 556%

5 analysts

Silence Therapeutics PLC (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Silence Therapeutics PLC (ADR) Live Stock Price Today, Share Analysis and Chart

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates bot...

35.73% Fall from 52W High

SWOT Analysis

Silence Therapeutics PLC (ADR) Live Price Chart